Matches in SemOpenAlex for { <https://semopenalex.org/work/W3003282012> ?p ?o ?g. }
- W3003282012 endingPage "107" @default.
- W3003282012 startingPage "102" @default.
- W3003282012 abstract "World Health Organization estimates the annual global incidence of typhoid fever at 11-21 million cases and approximately 128 000 to 161 000 deaths. The currently used Vi-polysaccharides (Vi-PS) vaccines have been proven to be safe and efficacious in children 2 years and above. However, poor immunogenicity of Vi-PS was observed in children below 2 years of age. This Phase II study is the continuation of the previously published Phase I study that aims to evaluate the safety and immunogenicity of a novel Vi-DT Typhoid Conjugate Vaccine (Bio Farma) in subjects 6 to <24 months.An interventional, blinded, comparative, randomized phase II study was conducted from July 2018 until January 2019. There were 200 healthy subjects divided into two groups: trial and control groups. Inactivated poliovirus vaccine was given to control group. Immediate and delayed local and systemic reactions up to 28 days post vaccination were recorded. Antibody titers were measured prior to vaccination (V1) and 28 days post vaccination (V2).The study showed that the seroconversion of Vi-DT vaccine 98.99%. One dose of Vi-DT vaccine induced higher geometric mean titers (GMT) in all subjects compared to that of baseline. Pain was the most common immediate and delayed local reaction. Immediate and delayed systemic reactions that mostly occurred was fever. There were no serious adverse events reported within 28 days post vaccination.The novel typhoid Vi-DT conjugate vaccine is safe and immunogenic in children 6 to <24 months.NCT03460405." @default.
- W3003282012 created "2020-02-07" @default.
- W3003282012 creator A5001276814 @default.
- W3003282012 creator A5005490903 @default.
- W3003282012 creator A5005684153 @default.
- W3003282012 creator A5028005100 @default.
- W3003282012 creator A5042246071 @default.
- W3003282012 creator A5044269224 @default.
- W3003282012 creator A5045402223 @default.
- W3003282012 creator A5050729780 @default.
- W3003282012 creator A5054951758 @default.
- W3003282012 creator A5057085178 @default.
- W3003282012 creator A5060047209 @default.
- W3003282012 creator A5076039500 @default.
- W3003282012 creator A5081145803 @default.
- W3003282012 date "2020-04-01" @default.
- W3003282012 modified "2023-09-28" @default.
- W3003282012 title "One-month follow up of a randomized clinical trial-phase II study in 6 to <24 months old Indonesian subjects: Safety and immunogenicity of Vi-DT Typhoid Conjugate Vaccine" @default.
- W3003282012 cites W1968151569 @default.
- W3003282012 cites W1969104565 @default.
- W3003282012 cites W2049532298 @default.
- W3003282012 cites W2147278081 @default.
- W3003282012 cites W2195372528 @default.
- W3003282012 cites W2415729072 @default.
- W3003282012 cites W2419529528 @default.
- W3003282012 cites W2575233916 @default.
- W3003282012 cites W2598694840 @default.
- W3003282012 cites W2603477349 @default.
- W3003282012 cites W2616147260 @default.
- W3003282012 cites W2759562520 @default.
- W3003282012 cites W2783720063 @default.
- W3003282012 cites W2805895293 @default.
- W3003282012 cites W2810103791 @default.
- W3003282012 cites W2811391733 @default.
- W3003282012 cites W2897448292 @default.
- W3003282012 cites W2915017368 @default.
- W3003282012 cites W2920892288 @default.
- W3003282012 cites W4297835529 @default.
- W3003282012 cites W2920974691 @default.
- W3003282012 doi "https://doi.org/10.1016/j.ijid.2020.01.045" @default.
- W3003282012 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32004693" @default.
- W3003282012 hasPublicationYear "2020" @default.
- W3003282012 type Work @default.
- W3003282012 sameAs 3003282012 @default.
- W3003282012 citedByCount "5" @default.
- W3003282012 countsByYear W30032820122020 @default.
- W3003282012 countsByYear W30032820122021 @default.
- W3003282012 countsByYear W30032820122023 @default.
- W3003282012 crossrefType "journal-article" @default.
- W3003282012 hasAuthorship W3003282012A5001276814 @default.
- W3003282012 hasAuthorship W3003282012A5005490903 @default.
- W3003282012 hasAuthorship W3003282012A5005684153 @default.
- W3003282012 hasAuthorship W3003282012A5028005100 @default.
- W3003282012 hasAuthorship W3003282012A5042246071 @default.
- W3003282012 hasAuthorship W3003282012A5044269224 @default.
- W3003282012 hasAuthorship W3003282012A5045402223 @default.
- W3003282012 hasAuthorship W3003282012A5050729780 @default.
- W3003282012 hasAuthorship W3003282012A5054951758 @default.
- W3003282012 hasAuthorship W3003282012A5057085178 @default.
- W3003282012 hasAuthorship W3003282012A5060047209 @default.
- W3003282012 hasAuthorship W3003282012A5076039500 @default.
- W3003282012 hasAuthorship W3003282012A5081145803 @default.
- W3003282012 hasBestOaLocation W30032820121 @default.
- W3003282012 hasConcept C126322002 @default.
- W3003282012 hasConcept C159047783 @default.
- W3003282012 hasConcept C159654299 @default.
- W3003282012 hasConcept C168563851 @default.
- W3003282012 hasConcept C187212893 @default.
- W3003282012 hasConcept C197934379 @default.
- W3003282012 hasConcept C203014093 @default.
- W3003282012 hasConcept C22070199 @default.
- W3003282012 hasConcept C2776714567 @default.
- W3003282012 hasConcept C2777451964 @default.
- W3003282012 hasConcept C2779583294 @default.
- W3003282012 hasConcept C2780868878 @default.
- W3003282012 hasConcept C520601542 @default.
- W3003282012 hasConcept C71924100 @default.
- W3003282012 hasConceptScore W3003282012C126322002 @default.
- W3003282012 hasConceptScore W3003282012C159047783 @default.
- W3003282012 hasConceptScore W3003282012C159654299 @default.
- W3003282012 hasConceptScore W3003282012C168563851 @default.
- W3003282012 hasConceptScore W3003282012C187212893 @default.
- W3003282012 hasConceptScore W3003282012C197934379 @default.
- W3003282012 hasConceptScore W3003282012C203014093 @default.
- W3003282012 hasConceptScore W3003282012C22070199 @default.
- W3003282012 hasConceptScore W3003282012C2776714567 @default.
- W3003282012 hasConceptScore W3003282012C2777451964 @default.
- W3003282012 hasConceptScore W3003282012C2779583294 @default.
- W3003282012 hasConceptScore W3003282012C2780868878 @default.
- W3003282012 hasConceptScore W3003282012C520601542 @default.
- W3003282012 hasConceptScore W3003282012C71924100 @default.
- W3003282012 hasLocation W30032820121 @default.
- W3003282012 hasLocation W30032820122 @default.
- W3003282012 hasLocation W30032820123 @default.
- W3003282012 hasOpenAccess W3003282012 @default.
- W3003282012 hasPrimaryLocation W30032820121 @default.
- W3003282012 hasRelatedWork W1985831871 @default.
- W3003282012 hasRelatedWork W1993478645 @default.